Dr. Joseph Francis McLaughlin, MD

  • Teaneck, NJ
  • Medical oncologist
NPI1013178466PAC ID7416279856
Medicare services, 2024
39,205
Medicare patients, 2024
498
Part D claims, 2024
2,243
Publications
6
Clinical trials
5
Practice address
500 Frank W Burr Blvd, Teaneck, NJ 07666
Practice phone
Call (860) 533-3091
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Regional Cancer Care Associates

Teaneck, New Jersey

See all 10 affiliations

Find Dr. McLaughlin's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Joseph Francis McLaughlin is a medical oncologist in Teaneck, New Jersey

Dr. McLaughlin practices at Regional Cancer Care Associates in Teaneck, New Jersey.

Dr. McLaughlin's NPI, 1013178466, was assigned on June 18, 2008. Dr. McLaughlin holds Connecticut license 49687.

NPI and contact details
Medicare PAC ID
7416279856
NPI enumeration date
June 18, 2008
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(860) 533-3091
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
44
Medical school graduation
2008

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Joseph Francis McLaughlin practices at Regional Cancer Care Associates in Teaneck, New Jersey

Dr. McLaughlin's primary practice is Regional Cancer Care Associates, at 500 Frank W Burr Blvd, Teaneck, NJ 07666 in Bergen County. The practice phone is (860) 533-3091.

  • Regional Cancer Care Associates
    500 Frank W Burr Blvd, Teaneck, NJ 07666 · Bergen CountyPhone(860) 533-3091

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Joseph Francis McLaughlin is affiliated with 9 sites of care and 1 medical group

Dr. McLaughlin's primary practice is Regional Cancer Care Associates in Teaneck, New Jersey. Dr. McLaughlin is also affiliated with Manchester Memorial Hospital. The medical group on file is Regional Cancer Care Associates. Dmand AI also links Dr. McLaughlin to 1 more hospital, 2 home health agencies, 2 hospices, 1 physician office and 1 group practice or clinic, each named with a free account.

See all 10 affiliations for Dr. McLaughlin

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Joseph Francis McLaughlin's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McLaughlin practices, 8 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Regional Cancer Care AssociatesAvailable with a free account
+8 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. McLaughlin practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Joseph Francis McLaughlin is one of 115 medical oncologists in New Jersey

Medical oncology is Dr. McLaughlin's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. McLaughlin is licensed in Connecticut.

Specialties and state licenses

  • Medical oncology, ConnecticutPrimaryLicense 49687 · taxonomy 207RX0202X

Medical oncologists near Dr. McLaughlin

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

115medical oncologists in New Jersey
6medical oncologists in Teaneck

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Joseph Francis McLaughlin billed Medicare for 39,205 services in 2024

CMS data shows 39,205 Medicare services from Dr. McLaughlin across 30 procedure codes in 2024, for 498 Medicare patients. Medicare paid $999,686 for them.

Medicare services, 202439,205
Medicare patients498
Paid by Medicare$999,686
Procedure codes30

Dr. McLaughlin's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 21,2892024: 35,48667%
Tests and treatments
2023: 1,4552024: 2,18450%
Office and hospital visits
2023: 1,0152024: 1,51850%
Surgery
2023: 02024: 17
Other services
2023: 5402024: 0100%

Where Dr. McLaughlin's Medicare services took place, 2024

  • In an office39,147100%
  • In a facility580%

Dr. McLaughlin compared with the New Jersey median for medical oncologists, 2024

  • Dr. McLaughlin
  • New Jersey median
Medicare services
39,205vs 72354.2 times
Medicare patients
498vs 2322.1 times
Part D claims
1,952vs 3595.4 times

Medians across 107 medical oncologists in New Jersey with Dmand AI profiles that report each measure.

Dr. McLaughlin's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. McLaughlin

Need commercial claims for Dr. McLaughlin?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. McLaughlin and other medical oncologists in New Jersey.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Joseph Francis McLaughlin treated 498 Medicare patients in 2024, average age 76

CMS counts 498 Medicare patients who saw Dr. McLaughlin in 2024. The largest group is 75 to 84, with 195 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 23% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McLaughlin's median patient age at 74, with 61% women.

Medicare patients, 2024498
Average age76
Average risk score1.97
Also on Medicaid23%

Dr. McLaughlin's Medicare patients by age, 2024

Dr. McLaughlin's Medicare patients by sex, 2024

  • Women28056%
  • Men21844%

Chronic conditions among Dr. McLaughlin's Medicare patients, 2024

  1. High cholesterol75%
  2. High blood pressure74%
  3. Cancer43%
  4. Arthritis38%
  5. Diabetes36%
  6. Ischemic heart disease32%
  7. Chronic kidney disease29%
  8. Anxiety26%

Share of Medicare patients with each condition. A patient can have several.

Dr. McLaughlin's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 74

Patient panel by sex, all payers

  • Women61%
  • Men37%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Joseph Francis McLaughlin wrote 2,243 Medicare Part D claims in 2024

In 2024, Dr. McLaughlin wrote 2,243 Medicare Part D claims for 348 patients. 69% of them were for generic drugs. CMS names the drug for 1,952 of them, across 36 drugs with 11 or more claims each, at $6,526,090 in total drug cost. In 2023, CMS named 1,622 claims across 31 drugs.

Part D claims, 20242,243
Drugs named by CMS36
Total drug cost$6.5M
Part D patients348

Dr. McLaughlin's Part D claims by kind of drug, 2024

  • Generic1,539 claims69%
  • Brand-name704 claims31%

Dr. McLaughlin's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. McLaughlin's Part D claims, 2024

  • Opioids3%57 of 2,243 claims
  • Antibiotics1%29 of 2,243 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,6222024: 1,95220%

Drugs named by CMS: 36 in 2024, 31 in 2023.

See all prescribing by Dr. McLaughlin

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Joseph Francis McLaughlin scored 91 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. McLaughlin for performance year 2024, reported individually. Dr. McLaughlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. McLaughlin's MIPS scores, performance year 2024

  • 91of 100Final score
  • 71.8of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. McLaughlin by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Joseph Francis McLaughlin has 6 publications on record

Dmand AI links 6 papers to Dr. McLaughlin, published from 2015 to 2016. 2016 was the busiest year, with 3. The most frequent topics are Lung Neoplasms, Biomarkers, Tumor and Carcinoma, Non-Small-Cell Lung. Dr. McLaughlin's most frequent co-authors are Vamsidhar Velcheti, MD, Mehmet Altan, MD and Brian Samuel Henick, MD.

Papers6
Years published2015 to 2016

Topics Dr. McLaughlin writes about most

  • Lung Neoplasms
  • Biomarkers, Tumor
  • Carcinoma, Non-Small-Cell Lung
  • Immunohistochemistry

Dr. McLaughlin's most frequent co-authors

Recent publications by Dr. McLaughlin

See all 6 publications and co-authors

See who Dr. McLaughlin researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. McLaughlin works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Joseph Francis McLaughlin has worked on 5 clinical trials

Dmand AI links Dr. McLaughlin to 5 clinical trials, 3 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Biliary Tract Neoplasms. National Cancer Institute (NCI) sponsors the most, 3.

Clinical trials with Dr. McLaughlin by phase

  1. NonePhase 1: no trials
  2. 1Phase 2: 1 trial
  3. 3Phase 3: 3 trials
  4. NonePhase 4: no trials

Conditions in Dr. McLaughlin's trials

  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma, Bronchogenic
  • Biliary Tract Neoplasms
  • Uterine Cervical Neoplasms

Investigators on the most trials with Dr. McLaughlin

Recent clinical trials with Dr. McLaughlin

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Joseph Francis McLaughlin received $251,614 in industry payments from 2016 to 2025

CMS Open Payments shows 438 general payments to Dr. McLaughlin from 47 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 87% of the total. Bristol-Myers Squibb Company paid the most, $241,249.

General payments to Dr. McLaughlin by program year, 2016 to 2025

General payments to Dr. McLaughlin by kind, 2016 to 2025

$251.6Kin total
  • Speaker and faculty fees$219,07987%
  • Consulting fees$21,7749%
  • Food and beverage$8,4453%
  • Travel and lodging$1,8811%
  • Education$4350%

Companies that paid Dr. McLaughlin the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. McLaughlin

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Joseph Francis McLaughlin's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Joseph Francis McLaughlin

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Joseph Francis McLaughlin's NPI number?

Dr. Joseph Francis McLaughlin's NPI number is 1013178466. It was assigned on June 18, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. Joseph Francis McLaughlin?

Dr. Joseph Francis McLaughlin is a medical oncologist in Teaneck, New Jersey. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Joseph Francis McLaughlin practice?

Dr. McLaughlin practices at 500 Frank W Burr Blvd, Teaneck, NJ 07666. Dr. McLaughlin's primary practice is Regional Cancer Care Associates in Teaneck, New Jersey. Dmand AI also links Dr. McLaughlin to 1 hospital, 2 home health agencies, 2 hospices, 1 physician office and 1 group practice or clinic.

What is Dr. Joseph Francis McLaughlin's office phone number?

The practice phone on file for Dr. McLaughlin is (860) 533-3091.

What is Dr. Joseph Francis McLaughlin's medical license number?

Dr. McLaughlin holds Connecticut license 49687.

Which hospitals is Dr. Joseph Francis McLaughlin affiliated with?

Dr. McLaughlin is affiliated with Manchester Memorial Hospital. Dmand AI links Dr. McLaughlin to 1 more hospital.

What medical group is Dr. Joseph Francis McLaughlin part of?

Dr. McLaughlin is linked to Regional Cancer Care Associates.

Does Dr. Joseph Francis McLaughlin accept Medicare?

Yes. CMS data shows Dr. McLaughlin billed Medicare for 39,205 services in 2024, and Dr. McLaughlin accepts Medicare assignment.

What is Dr. Joseph Francis McLaughlin's MIPS score?

Dr. McLaughlin's MIPS final score for performance year 2024 is 91 out of 100, reported individually.

How many Medicare patients does Dr. Joseph Francis McLaughlin see?

CMS counts 498 Medicare patients who saw Dr. McLaughlin in 2024, with an average age of 76.

Show 6 more questionsShow fewer questions

What services does Dr. Joseph Francis McLaughlin bill to Medicare?

In 2024, Dr. McLaughlin's most billed Medicare services were injected or infused drug (J9271), injected or infused drug (J0185) and injected or infused drug (J0897).

What drugs does Dr. Joseph Francis McLaughlin prescribe most?

In 2024 Medicare Part D data, Dr. McLaughlin's most prescribed drugs by claims were Anastrozole, Abiraterone Acetate and Prednisone.

Has Dr. Joseph Francis McLaughlin received payments from drug or device companies?

CMS Open Payments shows $251,614 in general payments to Dr. McLaughlin from 47 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.

How long has Dr. Joseph Francis McLaughlin been practicing?

Dr. McLaughlin graduated from medical school in 2008, 18 years ago.

Does Dr. Joseph Francis McLaughlin do research?

Dmand AI links 6 publications to Dr. McLaughlin, published from 2015 to 2016. Dr. McLaughlin has worked on 5 clinical trials.

Who does Dr. Joseph Francis McLaughlin publish with?

Dr. McLaughlin's most frequent co-authors are Vamsidhar Velcheti, MD (3 shared papers), Mehmet Altan, MD (2 shared papers) and Brian Samuel Henick, MD (1 shared paper).

Selling to medical oncology practices?

See medical oncologists in New Jersey by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)